RecruitingPulmonary Artery Stenosis
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
Eligible age
All ages
Accepts
All genders
Locations
8 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the clinical investigation is to characterize clinical outcomes and to assess the real-world use of the commercial PALMAZ MULLINS XD™ Pulmonary Stent.
Sponsor: Cordis US Corp.
Where it's recruiting
California
Sacramento
Georgia
Atlanta
Michigan
Detroit
Missouri
St Louis
Nebraska
Omaha
Ohio
Cincinnati
Pennsylvania
Pittsburgh
Texas
Houston
Source: ClinicalTrials.gov · NCT07122518 · last updated 2026-10-02